Yet another new study that sounds so promising, only to hear nothing about it a few months later. By the way, what happened to the joint study with Vermeer? Apart from the announcement, we've never heard anything about the results. Did Vermeer's machines ever actually arrive in Tanzania? But regardless, even the study must have cost money and probably won't be of any use since the strategy is likely to change again soon, leading to new studies. EGR should change its business model and focus on creating and profitably selling useless studies. That's something Andrew and his team are good at. They've been demonstrating it for 8 years and are world champions in producing useless studies and burning money with no added value for the company and shareholders. I'm curious how long the major shareholders will tolerate this behavior and the self-enrichment of the management.
Vote NO to this poor management in the next AGR!
- Forums
- ASX - By Stock
- EGR
- Ann: Study Confirms Attractive Mechanical Shaping Opportunity
EGR
ecograf limited
Add to My Watchlist
1.75%
!
28.0¢

Ann: Study Confirms Attractive Mechanical Shaping Opportunity, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $127.1M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 27.0¢ | $73.01K | 264.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7272 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 14597 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7272 | 0.275 |
1 | 3700 | 0.270 |
3 | 93700 | 0.265 |
2 | 5423 | 0.260 |
2 | 11176 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 14597 | 1 |
0.290 | 76322 | 3 |
0.295 | 147922 | 4 |
0.300 | 64300 | 5 |
0.305 | 3000 | 1 |
Last trade - 15.16pm 27/06/2025 (20 minute delay) ? |
Featured News
EGR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online